Kristen Hairston is an Endocrinology/Metabolic physician affiliated with Wake Forest University. OpenAlex indexes 38 publications with 3,915 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Dietary Intervention for Visceral Adiposity
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56.2%Insulin Analog22%Lantus Solostar29%Novolog Flexpen19%Humalog Kwikpen U-10014%Insulin Lispro Kwikpen U-10013%Tresiba Flextouch U-10013%Novolog12%Part D<11 patientsGLP-1 receptor agonist16.8%Ozempic66%Trulicity34%Part D≥25 patients+ 4 more classes in this area
Hormonal (systemic)
34%l-Thyroxine28.1%Levothyroxine Sodium64%Synthroid29%Tirosint7%Part D<11 patientsThyroid Hormone Synthesis Inhibitor3.4%Methimazole100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
4.7%Androgen4.7%Testosterone Cypionate64%Testosterone36%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2013–2014 per NIH RePORTER. The latest:
- Visceral Adipose Tissue as Mediator Between Lifestyle Factors and Cardiometabolic
Wake Forest University Health Sciences
FY2014$148,000R21DK095216 - Visceral Adipose Tissue as Mediator amid Lifestyle Factors & Cardiometabolic Risk
Wake Forest University Health Sciences
FY2013$282,688R21DK095216
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Yeboah, MD
Wake Forest University
Bayard Powell, MD
Wake Forest University
Joseph Jorizzo, MD
Wake Forest University
Edward Haponik, MD
Wake Forest University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”